ATE330003T1 - Rekombinanter stabiler zellklon, seine herstellung und verwendung - Google Patents

Rekombinanter stabiler zellklon, seine herstellung und verwendung

Info

Publication number
ATE330003T1
ATE330003T1 AT99939251T AT99939251T ATE330003T1 AT E330003 T1 ATE330003 T1 AT E330003T1 AT 99939251 T AT99939251 T AT 99939251T AT 99939251 T AT99939251 T AT 99939251T AT E330003 T1 ATE330003 T1 AT E330003T1
Authority
AT
Austria
Prior art keywords
cell clone
stabile
proteins
production
recombinant
Prior art date
Application number
AT99939251T
Other languages
German (de)
English (en)
Inventor
Manfred Reiter
Wolfgang Mundt
Friedrich Dorner
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3683861&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE330003(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Ag filed Critical Baxter Ag
Application granted granted Critical
Publication of ATE330003T1 publication Critical patent/ATE330003T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/005—Protein-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT99939251T 1999-08-05 1999-08-05 Rekombinanter stabiler zellklon, seine herstellung und verwendung ATE330003T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/AT1999/000197 WO2001011021A1 (de) 1999-08-05 1999-08-05 Rekombinanter stabiler zellklon, seine herstellung und verwendung

Publications (1)

Publication Number Publication Date
ATE330003T1 true ATE330003T1 (de) 2006-07-15

Family

ID=3683861

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99939251T ATE330003T1 (de) 1999-08-05 1999-08-05 Rekombinanter stabiler zellklon, seine herstellung und verwendung

Country Status (11)

Country Link
EP (1) EP1200561B1 (https=)
JP (1) JP2003506077A (https=)
AT (1) ATE330003T1 (https=)
AU (1) AU780810B2 (https=)
CA (1) CA2381173A1 (https=)
CY (1) CY1106111T1 (https=)
DE (1) DE59913565D1 (https=)
DK (1) DK1200561T3 (https=)
ES (1) ES2267280T3 (https=)
PT (1) PT1200561E (https=)
WO (1) WO2001011021A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1482031B1 (en) 1996-08-30 2015-10-28 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
EP1325127B1 (en) * 2000-10-02 2009-03-11 Novo Nordisk Health Care AG Method for the production of vitamin k-dependent proteins
EP1434857B1 (en) 2001-10-02 2007-08-01 Novo Nordisk Health Care AG Method for production of recombinant proteins in eukaryote cells
HUP0402226A2 (hu) * 2001-11-28 2005-02-28 Sandoz Ag. Eljárás sejttenyésztésre
WO2003048357A1 (fr) * 2001-12-04 2003-06-12 Mitsubishi Pharma Corporation Procede d'activation de proteine
PT2287288E (pt) 2002-07-09 2012-12-10 Baxter Int Meio isento de proteína animal para cultura de células
DE10338531A1 (de) * 2003-08-19 2005-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Reklonierung von Produktionszellen
US8669109B2 (en) 2003-08-19 2014-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Methods of producing proteins in Chinese hamster ovary (CHO) cells
JP2008504008A (ja) * 2003-12-31 2008-02-14 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング 改良された薬物動態を有するＦｃ−エリスロポエチン融合タンパク質
US20060094104A1 (en) * 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
AU2011221414B2 (en) * 2004-10-29 2012-09-20 Takeda Pharmaceutical Company Limited Animal Protein-Free Media for Cultivation of Cells
ATE541919T1 (de) 2005-02-11 2012-02-15 Novo Nordisk Healthcare Ag Herstellung eines proteins in serumfreier zellkultur, die ein proteinhydrolysat aus pflanzen enthält
EP3653699A1 (en) 2006-01-04 2020-05-20 Baxalta Incorporated Oligopeptide-free cell culture media
CA2742107A1 (en) 2008-11-12 2010-05-20 Baxter International Inc. Method of producing serum-free insulin-free factor vii
WO2024024671A1 (ja) * 2022-07-27 2024-02-01 不二製油グループ本社株式会社 動物細胞増殖促進剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
DE4313620A1 (de) * 1993-04-26 1994-10-27 Biotechnolog Forschung Gmbh Hamsterzellinien und Verfahren zur Glykoproteingewinnung
EP0666312A1 (en) * 1994-02-08 1995-08-09 Wolfgang A. Renner Process for the improvement of mammalian cell growth
ES2378409T3 (es) * 1994-11-10 2012-04-12 Baxter Healthcare S.A. Método para producir sustancias biológicas en cultivo sin proteínas
EP0799310A1 (en) * 1994-12-16 1997-10-08 Novartis AG Production of recombinant secretory component
AUPN442295A0 (en) * 1995-07-26 1995-08-17 Commonwealth Scientific And Industrial Research Organisation Regulated autocrine growth of mammalian cells
US5851800A (en) * 1996-05-14 1998-12-22 Pharmacia & Upjohn Ab Process for producing a protein

Also Published As

Publication number Publication date
DE59913565D1 (de) 2006-07-27
CY1106111T1 (el) 2011-06-08
WO2001011021A1 (de) 2001-02-15
ES2267280T3 (es) 2007-03-01
DK1200561T3 (da) 2006-10-16
AU5363699A (en) 2001-03-05
CA2381173A1 (en) 2001-02-15
PT1200561E (pt) 2006-09-29
EP1200561B1 (de) 2006-06-14
JP2003506077A (ja) 2003-02-18
AU780810B2 (en) 2005-04-21
EP1200561A1 (de) 2002-05-02

Similar Documents

Publication Publication Date Title
ATE330003T1 (de) Rekombinanter stabiler zellklon, seine herstellung und verwendung
HUP0101136A2 (hu) Fehérjeexpresszió baculovírus-vektort alkalmazó expressziós rendszerben
ATE12255T1 (de) Verfahren zur herstellung von selbstreproduzierenden pankreatischen inseln aehnlichen strukturen von saeugetieren.
DE3580654D1 (de) Menschlicher hybridomfusionspartner zur herstellung menschlicher monoklonaler antikoerper.
ATE187176T1 (de) Verfahren zur herstellung von heterologen bispezifischen antikörpern
DE69332981D1 (de) Methoden zur herstellung löslicher, oligomerer proteine
DK0843961T3 (da) Kimærisk mus og fremgangsmåde til at producere samme
ATE405644T1 (de) Verfahren zur herstellung und reinigung von erythropoietin
ATE359358T1 (de) Verfahren und medien zur kontrolle der sialysierung von proteinen, die von säugetierzellen produziert werden
ATE464373T1 (de) Zelluläre zusammensetzungen und verfahren zur deren bereitung und verwendung
FI820075L (fi) Rekombination-dna-medel och foerfarande
DE69935978D1 (de) Kulturmedium zur kultivierung tierischer zellen und verfahren zur herstellung von proteinen durch dessen verwendung
ATE153214T1 (de) Medien zur zellzucht und verfahren dazu
DE69722900D1 (de) Verfahren zur Herstellung von einer stabilen Troponin-Zubereitung und ihre Verwendung als Kalibrator/Kontrolle in Immunoassays
ATE220714T1 (de) Verfahren zur herstellung von proteinen
DE69425809D1 (de) Methoden zur Herstellung von Protein C
KR890005272A (ko) 흉선 간질-유래 t세포 성장인자 및 그의 제조방법
ATE103989T1 (de) Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung.
ATE428721T1 (de) Verfahren zur herstellung von wachstumshormon und antagonisten davon mit geringeren konzentrationen an isoformen verunreinigungen davon
DE60042273D1 (de) Antitumorantikörper, proteine und deren verwendung
ATE168117T1 (de) Proteine mit onkostatin-m-aktivität und verfahren zu ihrer herstellung
ATE96177T1 (de) Fibrinspezifischer antikoerper, verfahren zu seiner herstellung und seine verwendung.
DE69923595D1 (de) Herstellung von proteinen
ATE470700T1 (de) Bazillus zelle für die herstellung von proteinen
LT2005053A (en) Method of obtaining cell lines in a protein-free medium and cell lines thus obtained